Discovery of novel aniline-pyrimidine analogues as orally bioavailable dual VEGFR-2/tubulin inhibitors with potent antitumor and anti-angiogenesis efficacy.
- DOI
- 10.1016/j.bioorg.2025.109233
- Published
- 2025 Dec
- Container
- Bioorganic chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bioorg.2025.109233,
title = {Discovery of novel aniline-pyrimidine analogues as orally bioavailable dual VEGFR-2/tubulin inhibitors with potent antitumor and anti-angiogenesis efficacy.},
author = {Chu Y and Huang G and Yao Y and Wang A and Zhang Y and Yang H and Sun M and Duan Y},
year = {2025},
journal = {Bioorganic chemistry},
doi = {10.1016/j.bioorg.2025.109233},
url = {https://doi.org/10.1016/j.bioorg.2025.109233}
}RIS
TY - JOUR TI - Discovery of novel aniline-pyrimidine analogues as orally bioavailable dual VEGFR-2/tubulin inhibitors with potent antitumor and anti-angiogenesis efficacy. AU - Chu Y AU - Huang G AU - Yao Y AU - Wang A AU - Zhang Y AU - Yang H AU - Sun M AU - Duan Y PY - 2025 JO - Bioorganic chemistry DO - 10.1016/j.bioorg.2025.109233 UR - https://doi.org/10.1016/j.bioorg.2025.109233 ER -
APA
Y, C., G, H., Y, Y., A, W., Y, Z., H, Y., M, S., & Y, D. (2025). Discovery of novel aniline-pyrimidine analogues as orally bioavailable dual VEGFR-2/tubulin inhibitors with potent antitumor and anti-angiogenesis efficacy.. Bioorganic chemistry. https://doi.org/10.1016/j.bioorg.2025.109233
Source records
- pubmed · retrieved 2026-09-26T17:32:21.528Z